PhysioWave, Inc is a US-based startup that has developed a groundbreaking medical scale, aiming to revolutionize the assessment of cardiac risk. With the ability to provide a cardiac risk score digital biomarker in under a minute, PhysioWave's innovation sets it apart in the medical device industry. The company's scale can measure vacular age and Pulse Wave Velocity (PWV), a gold standard for arterial stiffness assessment, which has historically been challenging to measure accurately. PhysioWave's patented technology, approved by the FDA, stands to provide rapid, operator-independent, and reliable information crucial for individuals with cardiovascular disease, renal disease, hypertension, and congestive heart failure. Founded in 2005, PhysioWave operates in the Biopharma, Health Care, Manufacturing, and Medical Devices industries. As a content writer and startup investor analyst, I see potential in PhysioWave's disruptive technology and its impact on the healthcare sector.
There is no investment information
No recent news or press coverage available for PhysioWave, Inc.